Market Place
Sourcing Support
Vancouver Seniors Invited To Immune Restoration Trial
07 Jun 2024 //
GLOBENEWSWIRE
Qu Biologics, Foundation Partner For Late-Stage Colorectal Cancer Care
06 Jun 2024 //
GLOBENEWSWIRE
Dr. Matt Cahill Appointed Chief Operating Officer of Qu Biologics
23 Jan 2023 //
GLOBENEWSWIRE
Qu Biol & Karolinska Ins Initiate Collaboration to Validate Molecular Mechanisms
14 Dec 2022 //
GLOBENEWSWIRE
Qu Biologics to Receive Additional Funding to Support Innovative New Treatment
17 Oct 2022 //
GLOBENEWSWIRE
Qu Biologics to Launch Phase 2B Clinical Trial to Assess Reduction Postoperative
26 Sep 2022 //
GLOBENEWSWIRE
Qu Biologics to Receive Additional Funding to Launch Clinical Trial
20 Jul 2022 //
GLOBENEWSWIRE
Qu Biologics Closes USD$12M Equity Financing
21 Mar 2022 //
GLOBENEWSWIRE
Qu Biologics’ Phase 2 RESTORE trial data presented
13 Jul 2021 //
GLOBENEWSWIRE
Qu Biologics Receives Additional Funding to Accelerate Clinical Development
23 Jun 2021 //
GLOBENEWSWIRE
Qu Biologics’ RESTORE Trial Selected for Oral Presentation at ECCO 2021
09 Jun 2021 //
GLOBENEWSWIRE
Positive Signals for Endoscopic and Histologic Response in Patients
04 Jan 2021 //
GLOBENEWSWIRE
Qu Biologics Receives Funding for COVID-19 Prevention/Treatment Research
18 Dec 2020 //
GLOBENEWSWIRE
Qu Biologics Receives Funding for COVID-19 Prevention/Treatment Research
18 Dec 2020 //
GLOBENEWSWIRE
Qu Biologics Initiates Ph2 Study to Assess Activation of Anti-cancer Immune
18 Aug 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.